be_ixf;ym_202512 d_18; ct_50
NYSE:F charts & data provided by TradingView

Latest Insights on F

Should you invest in Novo Nordisk's Ozempic? Should You Invest In “Miracle Drug” Ozempic? November 17, 2023 by Adam O'Dell Banyan Edge, Diversified Investments, Trending From Chealsea Handler to Elon Musk, Novo Nordisk's Ozempic has been hailed a "miracle drug." Is it worth investing in?
Elon Musk's vision of AI is not what you think. Elon Musk’s Vision of AI Isn’t What You Think November 16, 2023 by Michael Carr Banyan Edge, Technology, Trending Artificial intelligence is the latest “next big thing.” But Elon Musk's vision of AI has it replacing us all. (We're a long way from that.)
Earnings season calls and CEO moves. Watch a CEO During Earnings Season for When to Invest November 15, 2023 by Charles Mizrahi Banyan Edge, Investing, Stocks Every 13 weeks, all publicly traded companies file a quarterly report. It's "earnings season." Watch a company's CEO to take investing cues.
2024: The Year of Artificial intelligence 2024: The Year of Artificial Intelligence November 14, 2023 by Ian King Banyan Edge, Investment Opportunities, Technology 2024 will be the year that AI takes off. Find out how you can invest in artificial intelligence as it takes us into the new year and beyond!
AI pushes Big Tech back to profitability. AI Backs a Big Tech Breakout: Amazon Is Leading the Way November 13, 2023 by Banyan Edge Team Banyan Edge, Investment Opportunities, Technology, U.S. Economy It’s official: Big Tech is making a comeback. Now in Q3 2023, the "big five" tech companies are back to their 2020 highs, thanks to AI.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving this. Should have started a long time ago.”

- Jay

“Looks like I have finally found the right person to learn and grow from.”

- James

“I started with $215,000 in Nov. 2018, It is now over 800,000. So very happy with Banyan Hill Publishing.”

- Larry K.

Share This